Critical Limb Ischemia Treatment Market Size to Reach USD 7.03 Billion by 2031 Amid Growing Adoption of Revascularization

Mordor Intelligence has published a new report on critical limb ischemia treatment market, offering a comprehensive analysis of trends, growth drivers, and future projections.
Critical Limb Ischemia Treatment Market Overview

According to Mordor Intelligence, the critical limb ischemia treatment market size [https://www.mordorintelligence.com/industry-reports/critical-limb-ischemia-treatment-market?utm_source=abnewswire] was valued at USD 5.19 billion in 2025 and is estimated to grow from USD 5.47 billion in 2026 to reach USD 7.03 billion by 2031, registering a CAGR of 5.15% during the forecast period.

Critical limb ischemia is one of the most severe forms of peripheral artery disease and is associated with reduced blood flow to the limbs, chronic pain, non-healing wounds, and increased risk of amputation. The growing prevalence of diabetes, cardiovascular disorders, obesity, and aging populations is contributing to a rising patient pool requiring advanced treatment options.

The critical limb ischemia treatment market continues to expand as healthcare providers focus on early diagnosis, improved vascular intervention techniques, and comprehensive wound management strategies. Device-based revascularization remains the primary treatment approach, while emerging regenerative and cell-based therapies are creating additional opportunities for patients with limited treatment options.

Critical Limb Ischemia Treatment Market Trends

Increasing Adoption of Device-Based Revascularization Procedures

One of the most significant critical limb ischemia treatment market trends is the continued use of revascularization procedures as the preferred treatment approach. Technologies such as balloon dilators, vascular stents, drug-eluting stents, and peripheral dilation systems are widely utilized to restore blood flow and preserve limb function. These interventions remain central to treatment strategies across healthcare settings.

Growing Interest in Regenerative and Cell-Based Therapies

The critical limb ischemia treatment industry is witnessing increasing attention toward regenerative medicine. Cell-based therapies are being explored as potential options for patients who may not be suitable candidates for conventional revascularization procedures. Healthcare providers are evaluating these therapies for their ability to support tissue repair and improve circulation in affected limbs.

Expansion of Ambulatory and Specialized Care Centers

Ambulatory surgical centers and specialty vascular clinics are becoming increasingly important in the treatment landscape. These facilities offer access to advanced vascular procedures while supporting efficient patient management. The expansion of specialized treatment centers is contributing to critical limb ischemia treatment market growth across multiple regions.

Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights: https://www.mordorintelligence.com/ja/industry-reports/critical-limb-ischemia-treatment-market?utm_source=abnewswire

Critical Limb Ischemia Treatment Market Segmentation

By Treatment Type

*
Devices

*
Embolic Protection Devices

*
Peripheral Dilatation Systems

*
Balloon Dilators

*
Vascular & Drug-Eluting Stents

*
Drugs

*
Antiplatelet Agents

*
Antihypertensive Agents

*
Lipid-Lowering Agents

*
Antithrombotic Agents

*
Regenerative & Cell-Based Therapies

By End-User

*
Hospitals

*
Ambulatory Surgical Centers

*
Specialty Vascular & Wound-Care Clinics

By Geography

*
North America

*
Europe

*
Asia-Pacific

*
Middle East & Africa

*
South America

Key Players in the Critical Limb Ischemia Treatment Market

The critical limb ischemia treatment market is highly competitive, with established medical device manufacturers, pharmaceutical companies, and emerging regenerative therapy developers competing to strengthen their positions. Market participants continue to focus on expanding treatment portfolios, enhancing clinical outcomes, and improving access to advanced vascular care solutions.

Key players operating in the market include:

*
LimFlow SA

*
Cardiovascular Systems, Inc.

*
Eli Lilly and Company

*
Abbott Laboratories

*
Medtronic

Conclusion

The critical limb ischemia treatment market is expected to witness steady growth as healthcare systems place greater emphasis on early intervention, limb preservation, and improved patient outcomes. Rising rates of diabetes, peripheral artery disease, and cardiovascular disorders continue to create demand for effective treatment solutions worldwide.

Device-based revascularization remains the foundation of treatment, while regenerative and cell-based therapies are emerging as promising options for selected patient populations. The increasing availability of advanced vascular interventions is supporting positive developments across the critical limb ischemia treatment industry.

Hospitals, ambulatory surgical centers, and specialty vascular clinics are expanding access to innovative treatment technologies, helping patients receive timely care and reducing the likelihood of severe complications. At the same time, advancements in diagnostic imaging and treatment planning are improving clinical decision-making and procedural success rates.

Industry Related Reports

United States Dermatological Drugs Market:

The United States dermatological drugs market is growing due to the increasing prevalence of skin disorders such as acne, psoriasis, and atopic dermatitis, along with rising demand for advanced treatment options. Continued innovation in biologics and targeted therapies is further supporting market expansion.

Get more insights: https://www.mordorintelligence.com/industry-reports/united-states-dermatological-drugs-market?utm_source=abnewswire

Cervical Dystonia Treatment Market Size:

The cervical dystonia treatment market is projected to grow from USD 577.12 million in 2025 to USD 753.72 million by 2031, registering a CAGR of 4.55% during 2026-2031. Growth is driven by increasing awareness of neurological disorders, improved diagnosis rates, and the availability of advanced treatment options such as botulinum toxin therapies.

Get more insights: https://www.mordorintelligence.com/industry-reports/cervical-dystonia-treatment-market?utm_source=abnewswire

Hedgehog Pathway Inhibitors Market Share:

The hedgehog pathway inhibitors market is expected to grow from USD 0.79 billion in 2025 to USD 1.52 billion by 2031, expanding at a CAGR of 11.52% during the forecast period. Rising incidence of cancers associated with hedgehog signaling pathways, growing adoption of targeted therapies, and ongoing oncology research are driving market growth.

Get more insights: https://www.mordorintelligence.com/industry-reports/hedgehog-pathway-inhibitors-market?utm_source=abnewswire

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com

https://www.mordorintelligence.com/

Media Contact
Company Name: Mordor Intelligence Private Limited
Contact Person: Jignesh Thakkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=critical-limb-ischemia-treatment-market-size-to-reach-usd-703-billion-by-2031-amid-growing-adoption-of-revascularization]
Phone: +1 617-765-2493
Address:11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli
City: Hyderabad
State: Telangana 500008
Country: India
Website: https://www.mordorintelligence.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.